医疗机构中药临方加工服务临床应用情况分析
Analysis of Clinical Application of Traditional Chinese Medicine Prescription Processing Service in Medical Institutions
摘要: 目的:通过对某医疗机构中药临方加工服务的开展情况进行总结分析,以期为推动此项服务的创新发展提供有益参考。方法:选取2023~2024年医疗机构临方加工的处方数据,通过Excel开展回顾性统计分析,系统评价其临床应用情况。结果:2023~2024年共计加工处方89201张,占中药饮片总处方的6.75%,加工数量排名前3位科室分别为心血管内科、耳鼻咽喉头颈外科、眼科,主要加工剂型为丸剂、合剂、袋泡茶;患者年龄集中分布于51~60岁(25.10%),与慢性病高发年龄段吻合;处方诊断主要包含高血压、糖尿病、冠心病等慢性病病种。结论:中药临方加工服务具备良好的发展空间,同时在慢病管理领域呈现显著临床应用优势,能有效提升用药便捷性及患者依从性,可为医疗机构开展相关药学服务提供相应参考。
Abstract: Objective: To summarize and analyze the development of personalized processing service of traditional Chinese medicine (TCM) in a hospital, in order to provide a useful reference for promoting the innovative development of this service. Methods: The prescription data of personalized processing in a hospital from 2023 to 2024 were selected, and retrospective statistical analysis was carried out by Excel to systematically evaluate its clinical application. Results: A total of 89201 prescriptions were processed from 2023 to 2024, accounting for 6.75% of the total prescriptions of Chinese herbal pieces. The top three departments were cardiovascular medicine, otorhinolaryngology head and neck surgery and ophthalmology. The main processing dosage forms were pills, mixture and tea bags. The age of patients was concentrated in 51~60 years old (25.10%), which was consistent with the high incidence of chronic diseases. Prescription diagnosis mainly includes chronic diseases such as hypertension, diabetes, and coronary heart disease. Conclusion: The personalized processing service of TCM has a good development space, and shows significant clinical application advantages in the field of chronic disease management, which can effectively improve the convenience of medication and patient compliance, and can provide corresponding reference for medical institutions to carry out relevant pharmaceutical services.
参考文献
|
[1]
|
国家卫生部、国家中医药管理局、国家食品药品监督管理局. 关于印发加强医疗机构中药制剂管理意见的通知[EB/OL]. http://www.natcm.gov.cn/yizhengsi/gongzuodongtai/2018-03-24/3064.html, 2010-08-24.
|
|
[2]
|
国家中医管理局. 国象中医临床药学重点专科建设要求(2013版) [Z]. 北京: 国家中医管理局, 2013-08-27.
|
|
[3]
|
沈敏婕, 孔维崧, 薛亚, 等. 我院中药临方定制加工服务的分析[J]. 上海医药, 2024, 45(9): 92-97.
|
|
[4]
|
深圳市卫生健康委员会. 关于印发深圳市医疗机构中药临方制剂工作指南的通知[EB/OL]. https://wjw.sz.gov.cn/xxgk/tzgg/content/post_10390199.html, 2022-12-30.
|
|
[5]
|
国家中医药管理局办公室、国家中医药管理局办公室. 关于印发三级中医医院、三级中西医结合医院、三级民族医医院评市标准有关文件的通知[EB/OL]. http://yzs.satcm.gov,cn/zhengcewenjian/2018-03-24/3151.html, 2018-03-24.
|
|
[6]
|
洪燕龙, 王优杰, 沈岚, 等. 中药临方制剂的应用现状、问题分析和发展对策[J]. 中国中药杂志, 2021, 46(15): 3739-3745.
|
|
[7]
|
田文秀, 李文杰, 薛爱乐, 等. 中药临方制剂智能制造的研究实践与发展方向[J]. 中国中药杂志, 2024, 49(3): 571-579.
|
|
[8]
|
赵强, 袁强华, 朱聪, 等. 临方制剂在某院妇科应用情况及相关剂型制作浅析[J]. 中国处方药, 2022, 20(9): 72-75.
|
|
[9]
|
翟静波. 以患者为中心的中医药防治慢性病临床诊疗方案遴选与评价方法学框架[J]. 中国循证医学杂志, 2023, 23(4): 439-443.
|
|
[10]
|
于钦明, 王琪, 王启帆. 新形势下中医药防治慢性病的SWOT分析[J]. 时珍国医国药, 2021, 32(9): 2236-2239.
|